✦ LIBER ✦

Improved safety of basiliximab (Simulect®) over antithymocyte globulin (Thymoglobulin®) induction therapy in heart transplantation

✍ Scribed by M.F. Mattei; P. Boissonnat; M. Redonnet; I. Gandjbakhch; A. Mouly Bandini; R. Dorent; C. Yau; A.S. Blanc

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparative analysis of basiliximab (S

✍ K.C Stewart; T.J Guthrie; G Richardson; B.F Meyers; J.P Lynch; G.A Patterson; E. 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Efficacy and safety of induction therapy

✍ N. Kamar; D. Ribes; K. Sandres-Saune; B. Suc; K. Barange; O. Cointault; L. Lavay 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 95 KB